AAVogen

AAVogen

AAVogen is a biotech startup that develops gene therapeutics for muscle wasting diseases.
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$25.0k

Seed
N/A

$50.0k

Seed

$2.0m

Grant
N/A

$200k

Grant

$2.0m

Seed
*

$275k

Grant
Total FundingAUD7.0m

Recent News about AAVogen

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.